Unnamed stage
Our 4th newsletter detailing our investment in Qubigen
Synthesis BioVentures' fourth newsletter covers its backing of Qubigen; the captured page holds only a title and date, with no further detail.
Company
Qubigen
Funding history
Investors
Every investor coverage indicates participated in a round Qubigen raised.
What Qubigen bought
Companies Qubigen acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
Coverage
Stories naming Qubigen. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.